Whole-genome DNA methylation profiling in COVID-19 positive patients reveals alterations in pathways linked to neurological dysfunction
Authors:
- Saima ZameerSZSaima Zameer
- Ehraz AnisEAEhraz Anis
- Qiang ShaQSQiang Sha
- Martha L. Escobar GalvisMGMartha L. Escobar Galvis
- Sanam KhanSKSanam Khan
- Jennifer A. SteinerJSJennifer A. Steiner
- Milda MilčiūtėMMMilda Milčiūtė
- Ieva KerševičiūtėIKIeva Kerševičiūtė
- Migle GabrielaiteMGMigle Gabrielaite
- Juozas GordeviciusJGJuozas Gordevicius
- Andrew PospisilikAPAndrew Pospisilik
- Nazia SaiyedNSNazia Saiyed
Preprint
Abstract
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly transmissible RNA betacoronavirus, causing coronavirus disease-19 (COVID-19). Infection with SARS-CoV-2 can result in a broad spectrum of clinical outcomes, ranging from asymptomatic or mild to a severe, deadly illness. Emerging evidence suggests SARS-CoV-2 affects host gene regulation through epigenetic mechanisms, such as DNA methylation, potentially contributing to immune dysregulation and post-acute sequelae, including neurological and psychiatric disorders. However, the extent and functional relevance of these epigenetic changes remain uncertain. Methods and results: We employed whole-genome bisulfite sequencing to profile DNA methylation in peripheral blood from SARS-CoV-2-positive patients across a spectrum of symptom severity, ranging from asymptomatic to severe (n=101), in comparison to SARS-CoV-2-negative individuals (n=105). We observed a widespread hypomethylation in the genomes of infected individuals, which was more pronounced in severe cases. Notably, we identified differentially methylated genes in patients with mild (19 genes), moderate (19 genes), and severe (35 genes) symptoms. These genes included those involved in canonical immune responses as well as known to be linked to neurodegenerative diseases. Subsequent pathway enrichment analysis further supported the significant association between the differentially methylated genes and those implicated in Alzheimer’s and Parkinson’s disease, as well as neuropsychiatric conditions, suggesting potential epigenetic links between acute SARS-CoV-2 infection and long-term neurological outcomes. This is one of the first studies to comprehensively map severity-stratified genome-wide DNA methylation changes in COVID-19 patients. Conclusion: Our findings underscore the potential importance of epigenetic regulation in the acute responses to SARS-CoV-2 infection and highlight an overlap with epigenetic mechanisms relevant for neuropsychiatric disease processes.Keywords
This publication has 107 references indexed in Scilit:
- Plasma miRNAs across the Alzheimer's disease continuum: Relationship to central biomarkersAlzheimer's & Dementia, 2024
- Parallel electrophysiological abnormalities due to COVID‐19 infection and to Alzheimer's disease and related dementiaAlzheimer's & Dementia, 2024
- Alterations in Blood Methylome as Potential Epigenetic Biomarker in Sporadic Parkinson's DiseaseAnnals of Neurology, 2024
- Whole genome‐wide sequence analysis of long‐lived families (Long‐Life Family Study) identifies MTUS2 gene associated with late‐onset Alzheimer's diseaseAlzheimer's & Dementia, 2024
- Single‐nuclei RNA sequencing provides evidence for glial senescence in Alzheimer’s diseaseAlzheimer's & Dementia, 2023
- Neurological manifestations in patients with COVID‐19: A systematic review and meta‐analysisJournal of Clinical Laboratory Analysis, 2022
- Persistent neurologic symptoms and cognitive dysfunction in non‐hospitalized Covid‐19 “long haulers”Annals of Clinical and Translational Neurology, 2021
- Prevalence of Olfactory Dysfunction in Coronavirus Disease 2019 (COVID‐19): A Meta‐analysis of 27,492 PatientsThe Laryngoscope, 2020
- Central nervous system involvement by severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2)Journal of Medical Virology, 2020
- Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy conceptsJournal of Leukocyte Biology, 2020